Introduction
Sphingolipids are not only components of cellular membranes but also function as signaling molecules 1 3 . Many studies have shown that treatment of keratinocytes with sphingolipids accelerates differentiation 4 6 and de novo production of ceramides 7, 8 . Ceramides are major components of stratum corneum lipids that perform important barrier functions 9 . Patients with atopic dermatitis AD have fewer skin ceramides and altered ceramide composition compared to those without AD 10, 11 . Ceramide synthase 3 CerS3 and elongase of very long chain fatty acids ELOVL 1 and 4 are essential enzymes that produce ultralong-chain fatty acid ULCFA -bound ceramides, which are specifically expressed in skin tissues 12 14 . Mice lacking these genes die within several hours after birth because of rapid water loss from the skin 12 14 . Thus, the levels of skin ceramides and their fatty acid chain lengths are important factors in skin barrier functions.
The sphingoid bases d18:3, 9Me-d18:3, d22:1, d22:2, and t22:1 are produced by the starfish Asterias amurensis 8, 24, 25 .
Treatment of cultured human keratinocytes with sphingoid bases can induce differentiation and promote sphingolipid biosynthesis 7, 8, 26 . Previously, we reported that a mixture of sphingoid bases derived from A. amurensis induces the accumulation of ceramides, GlcCers, and SMs and up-regulates the mRNA expression levels of sphingolipid biosynthesis-related genes in undifferentiated keratinocytes 8 . In the present study, we isolated individual A. amurensis-derived sphingoid bases using a novel method involving Nacetyl derivatization and high-performance liquid chromatography HPLC with an octadecyl silyl ODS column. We next investigated whether structural differences between sphingolipid bases influence their activity using cultured keratinocytes.
Experimental 2.1 General reagents
HuMedia-KG2 medium, keratinocyte growth enhancers, and normal human epidermal keratinocytes from neonatal foreskin were purchased from Kurabo Osaka, Japan . PrimeScript RT Master Mix Perfect Real Time was purchased from Takara Bio, Inc. Shiga, Japan . TRIzol reagent was acquired from Thermo Fisher Scientific Waltham, MA, USA . A KAPA SYBR Fast qPCR kit was purchased from Kapa Biosystems Wilmington, MA, USA . N-Heptadecanoyl-D-erythro-sphingosine C17 ceramide; d18:1-C17:0 , N-heptadecanoyl-D-erythro-sphingosylphosphorylcholine C17 sphingomyelin; d18:1-C17:0 , D-glucosyl-1, 1 -N-lauroyl-D-erythro-sphingosine C12 glucosylceramide; d18:1-C12:0 , and D-erythro-sphingosine 2S,3S,4E -2-aminooctadec-4-ene-1,3-diol; d18:1 were purchased from Avanti Polar Lipids Alabaster, AL, USA . EnBio Nuclear Receptor Cofactor Assay System RCAS kits for peroxisome proliferator-activated receptor PPAR α, β, and γ were purchased from Fujikura Kasei Tokyo, Japan .
Preparation and isolation of sphingoid bases
Crude sphingoid bases from A. amurensis-derived GlcCers were prepared as previously reported 8, 27 . Asterias amurensis ethanol extract was separated on silica gel by gradient elution consisting of chloroform:methanol 10: 
Sphingolipid quanti cation by LC-MS/MS
Keratinocytes were exposed to sphingoid bases for 120 h, washed twice with 2 mL of phosphate-buffered saline, and resuspended in 1 mL of phosphate-buffered saline. Keratinocytes were transferred into a screw-capped glass test tube and mixed with chloroform 1 mL , methanol 1 mL , and 1 nmol of internal standards C17 ceramide, C12 glucosylceramide, and C17 sphingomyelin . After slight sonication, the test tubes were centrifuged at 1000 g for 5 min, and lower phases were transferred to fresh test tubes. Residual lipids were re-extracted with chloroform 1 mL and combined, and the resulting lower phases were dried under a nitrogen stream and treated with 0.4 M NaOH-methanol solution 1 mL at 37 for 2 h to remove the glycerolipids. Chloroform 1 mL and water 1 mL were added, and lipids were recovered from the lower phases and evaporated with a nitrogen stream. Cold acetone 1 mL was added to the dried residues and the samples were centrifuged at 1000 g at 4 for 5 min. The supernatants were discarded, and pelleted sphingolipids were retained.
LC-MS/MS analysis was carried out with a TripleTOF 5600 system AB SCIEX, Foster City, CA, USA in electrospray ionization ESI -positive mode 30 as previously de- 
RNA extraction and qPCR
Total RNA was extracted with TRIzol reagent, cDNA was synthesized using a PrimeScript RT Master Mix reagent kit according to the manufacturer s protocols, and qPCR was performed using a KAPA SYBR Fast qPCR kit. PCR primers used in this study are described in our previous reports 7, 8, 31 .
Relative gene expression was normalized to glyceraldehyde 3-phosphate dehydrogenase as an internal reference gene.
PPAR binding assay
RCAS kits were used for PPARα, β/δ, and γ binding assays according to the manufacturer s protocols, with GW7647, L165,041, and GW1929 used as positive controls, respectively. Test compounds were dissolved in DMSO and added to the assay mixtures.
Statistical analysis
Statistical analyses were performed by one-way analysis of variance with Dunnett s tests to identify the level of significance between groups. Data are presented as the mean SD, and p 0.05 was considered statistically significant.
Results

Separation and purification of A. amurensis-derived sphingoid bases
Crude sphingoid bases from A. amurensis GlcCers and their OPA derivatives were analyzed by HPLC, and several sphingoid bases were detected Fig. 1A and B . Initially, we attempted to separate each sphingoid base using a general monomeric ODS column and fractionated four portions , and others 9.8 mol . Sphingoid base composition ratio was calculated from peak area. C OPAderivatized fractions in A . :2a, and d22:2b for 120 h significantly increased the total amount of ceramides in keratinocytes, by 1.7-, 1.7-, and 1.6-fold, respectively, compared to in the control group Fig. 5A ; Table 1 . The amounts of d18:0-C24:1, d18:1-C26:1, d18:1-C26:0, d18:0-C26:1, d18:1-C28:1, and d18:0-C28:1 ceramides were significantly increased following exposure to d18:1 Fig. 5D ; Table 1 . All isolated A. amurensis-derived sphingoid bases increased C16-C20 fatty acid-bound ceramides Fig. 5D ; Table 1 . Remarkably, in keratinocytes treated with d18:3, but not other sphingoid bases, ULCFA-bound ceramides d18:1-C30:0, d18:1-C32:0, and d18:1-C34:0 were significantly increased by 2.3-, 4.5-, and 2.0-fold, respectively Fig. 5E ; Table 1 . Species of d18:1-C24:1 ceramides were increased in keratinocytes treated with d22:2a Fig. 5D ; Table 1 . The total amounts of GlcCers in d18:3-and d22:2a-treated keratinocytes were significantly increased by 2.7-and 2.4-fold compared to in the control group, but other sphingoid bases did not show this effect Fig. 5B ; Table 2 . For GlcCer species, d18:3 exposure stimulated the production of d18:1-C16:0, d18:1-C22:0, d18:1-C24:1, and d18:1-C24:0, while d22:2a exposure stimulated the production of d18:1-C24:1 Table 2 .
The total amounts of SM and d18:0-C18:0 SM were decreased following exposure of keratinocytes to 9Me-d18:3 Table 3 . Treatment with d22:2b increased the levels of d18:1-C18:0, d18:0-C18:0, and d18:1-C30:0 species and decreased d18:1-C24:0 d18:0-C24:1, d18:1-C26:1, and d18:1-C26:0 d18:0-C26:1 SMs Table 3 . These results suggest that each of the A. amurensis-derived sphingoid bases modified sphingolipid production in keratinocytes, and the strength of the effect differed depending on the sphingoid base structure.
Sphingoid bases stimulate keratinocyte differentiation
We next investigated the mRNA expression levels of sphingolipid biosynthesis-related genes serine palmitoyl transferase 2, ceramide synthase 2-5 CerS2-5 , elongase of very long chain fatty acids 1, 4-7 ELOVL1, 4-7 , Δ4 desaturase 1, glucosylceramide synthase, β-glucocerebrosidase, sphingomyelin synthase 1 and 2 SMS1 and 2 , and acidic sphingomyelinase aSMase . The mRNA levels of serine palmitoyl transferase 2, CerS3, 5 and 6, ELOVL5 and 6, β-glucocerebrosidase, and SMS1 and 2 were significantly increased in keratinocytes following treatment with d18:1 Fig. 6A . Exposure of keratinocytes to d18:3 resulted in increased ELOVL6 and SMS1 mRNA levels, while 9Me-d18:3 up-regulated ELOVL5 and 6, SMS1, and aSMase mRNAs Fig. 6A . Treatment of keratinocytes with d22:2a increased the mRNA levels of aSMase. To investigate the differentiation-promoting effects of each sphingoid base, the mRNA levels of keratin 14 and 10 K14 and 10 and involucrin, which are known differentiation marker genes in keratinocytes, were also analyzed Fig. 6B . Interestingly, the mRNA levels of the early differentiation marker gene K10 were significantly decreased after 120-h treatment with each sphingoid base Fig. 6B . These results suggest that sphingoid bases accelerate keratinocyte differentiation.
Asterias amurensis-derived sphingoid bases are potential ligands for PPARγ
To evaluate the relationships between the effects on keratinocyte differentiation and sphingoid base structure, we compared their PPAR binding activities Fig. 7A-C . Binding to PPARα, β, and δ was observed for both d22:2a and d22:2b Fig. 7A and B , and all isolated sphingoid bases bound strongly to PPARγ Fig. 7C . These results suggest that A. amurensis-derived sphingoid bases are ligands of PPARγ.
Discussion
Previous studies reported that dietary GlcCers can improve skin conditions in AD model mice and humans 15 18 .
Plant-derived sphingoid bases up-regulate ceramide synthesis in cultured keratinocytes, including three-dimensional reconstructed skin models 7, 18 . Although sphingoid bases display structural diversity, the relationships between their structures and effects on the skin remain unknown. In this study, we isolated four sphingoid bases from A. amurensis by N-acetyl derivatization and HPLC using a general ODS column and examined their individual effects on keratinocytes. We found that all A. amurensisderived sphingoid bases significantly elevated the ceramide levels in keratinocytes, but only d18:3 increased the content of ULCFA-bound ceramides. Additionally, A. amurensis-derived sphingoid bases stimulated keratinocyte differentiation, as indicated by down-regulation of the early differentiation marker gene K10, and all isolated sphingoid bases exhibited PPARγ binding activity. To isolate individual sphingoid bases by HPLC, we first selected phosphate-buffered aqueous and methanol solvents as the mobile phase, but satisfactory separation was not achieved Fig. 1A-C . This unusual elution behavior may have been caused by ionic interactions between free amino groups and residual silanol groups, and may be partially controlled by the pH of the mobile phase. Sphingoid bases of the d22:2 type have longer alkyl chains than other C18 sphingoid bases; thus, we predicted that chain length can also influence chromatographic behavior. Thus, we attempted to separate individual species by performing Nacetyl derivatization of sphingoid bases to prepare neutral compounds. Elution of N-acetyl sphingoid bases occurred in order of carbon number as predicted Fig. 2 , yielding individual sphingoid base species from the complex mixtures.
LC-MS/MS analysis showed that the total ceramide content in keratinocytes was significantly increased by treatment with d18:1, 9Me-d18:3, or the two d22:2 isomers and was increased by d18:3 Fig. 5A ; Table 1 . The levels of C26-28 fatty acid-bound ceramides were significantly increased following d18:1 exposure, and d18:3 significantly stimulated accumulation of saturated ULCFA C30-C34 -bound ceramides Fig. 5A ; Table 1 . The total amount of Fig. 6 Gene expression levels in keratinocytes treated with 30 µM d18:1, d18:3, 9Me-d18:3, d22:2a, or d22:2b. Keratinocytes were treated with the individual isolated sphingoid bases for 24 or 120 h, and mRNA levels were measured by realtime quantitative PCR. A Sphingolipid biosynthesis-related genes. B Differentiation marker genes. Data are normalized against glyceraldehyde 3-phosphate dehydrogenase GAPDH as an internal reference gene, and represented as mean standard deviation n 4 . *Significant differences from the control group at p 0.05.
GlcCers in keratinocytes was significantly increased by treatment with d18:3 or d22:2a Fig. 5B ; Table 2 . Ceramide and GlcCer increased with keratinocyte differentiation 32 34 . In the skin of patients with AD, ceramide levels are lower than in healthy skin 10 and different ceramide components are present 11 . Additionally, ceramides from impaired skin areas have shorter fatty acid chains compared to those from normal healthy areas 35 .
Mammals possess six ceramide synthases CerS1-6 and seven fatty acid elongases ELOVL1-7 9, 36 . In the skin epidermis, CerS3 is the predominant ceramide synthase subfamily 9, 37 , the members of which are highly specific for ≥ C18 acyl-CoA moieties, including ULCFA-acyl-CoA species 38, 39 . ELOVL1 produces C22-C26 fatty acids, while ELOVL4 generates longer-chain fatty acids ≥ C28 39, 40 . In CerS3-and ELOVL1/4-null mouse skin, ≥ C28 fatty acidbound ceramides are depleted, resulting in neonatal death 12 14 . This suggests that the amounts of skin ceramides and their fatty acid chain lengths are important for skin barrier formation. Ceramide accumulation induced by treatment with isomers of d18:1, d18:3, 9Me-d18:3, and d22:2 suggests that these sphingoid bases improve skin barrier function. Particularly, d18:3 may possess useful skin characteristics and stimulate the production of essential ULCFA-bound ceramides Fig. 5A ; Table 1 . In contrast, treatment with d22:2 isomers displayed lower levels of UL-CFA-bound ceramides, suggesting that they do not promote skin recovery Fig. 5A ; Table 1 . Accumulation of GlcCer occurs in parallel with keratinocyte differentiation 41 , and both d18:3 and d22:2a stimulated keratinocyte differentiation based on GlcCer accumulation. Additionally, exposure to 9Me-d18:3 decreased total SM levels, while other sphingoid bases had no such effect Fig. 5C ; Table 3 . Among the SMs, ≥ C26 fatty acid-bound molecular species were notably increased following exposure to d18:1, and similar results were observed with other sphingoid bases Fig. 5A and C; Tables 1 and 3 . The fatty acid length of sphingolipids changes during keratinocyte differentiation, and longer-chain fatty acids are increased in later stages 42 .
Exogenously added d18:1, d18:0, and t18:0 are thought to be incorporated, and these sphingoid bases are resynthesized in cultured keratinocytes to form sphingolipids such as ceramides, GlcCers, and SMs 26 . Thus, our results indicate that some d18:1 serves as a precursor for synthesizing ≥ C26 fatty acid-bound ceramides and SMs.
To investigate the mechanism of d18:3-specific regulation of ULCFA-bound ceramides and sphingolipid production, we analyzed the mRNA expression levels of sphingolipid biosynthesis-related genes. In d18:1-treated keratinocytes, the mRNA levels of CerS3 and ELOVL1 were significantly increased, while d18:3 caused no such change in ceramide synthesis-related gene expression, including CerS3 and ELOVL1/4 Fig. 6A . Furthermore, d18:3 had no notable effect on other sphingolipid synthesis-related genes. Therefore, we predicted that the effects on the expression of sphingolipid synthesis-related enzymes were not responsible for d18:3-specific bioactivity.
The fatty acid chain length of ceramides in keratinocytes is closely related to differentiation 42 . Thus, we also analyzed the mRNA expression levels of differentiation marker genes in keratinocytes. The mRNA levels of the early differentiation marker gene K10 were significantly decreased following 120-h incubation with each of the isolated sphingoid bases Fig. 6B . Differentiation can also be induced by high-density culture conditions, and differentiation-related genes are up-regulated in cultured keratinocytes 26, 43 45 .
K10 mRNA levels are increased in the early stages in confluent cultures and decreased during later stages of culturing 45 . A decrease in K10 mRNA levels, a spinous layer marker gene 46, 47 , suggests that the differentiation of keratinocytes is in a later stage, such as formation of the granular layer. Activation of PPARs is closely related to keratinocyte differentiation 48 51 . Herein, we investigated the relation- Fig. 7 Binding of individual isolated sphingoid bases to PPARs. Receptor binding was evaluated using the RCAS assay system for PPARα A , PPARβ/δ B , and PPARγ C . GW7647, L-165,041, and GW1929 served as positive control of PPARα, PPARβ/δ, and PPARγ, respectively. Data are represented as the mean absorbance at 540 nm standard deviation n 3 . *Significant differences from the control group at p 0.05.
ships between structurally different sphingoid bases and their PPAR binding activities. Although d18:3 specifically stimulated ULCFA-bound ceramide production, no characteristic PPAR binding activity was observed Fig. 7A -C . However, PPARγ binding assays revealed significant binding of all isolated sphingoid bases Fig. 6C . The d22:2 isomers have a longer carbon chain length than the d18:1, d18:3, and 9Me-d18:3 forms, which bind to PPARα. The carbon chain length of sphingoid bases may affect PPARα and β/δ binding Fig. 7A and B . Additionally, the plant-derived sphingoid base d18:2 is a potential PPARγ ligand 7 .
These sphingoid bases share a 2-amino-1,3-diol-4-ene moiety which may be required for PPARγ binding. We predicted that d18:3 enhances ULCFA-bound ceramide accumulation rather than PPARγ activation. Several studies have explored the keratinocyte differentiation mechanisms. Cyclooxygenase 2 expression is markedly increased in association with keratinocyte differentiation 52 , and keratinocytes produce prostanoids such as prostaglandin E2 in later stages of differentiation 53 . Prostaglandin E2 also stimulates keratinocyte differentiation via prostaglandin E2 receptor activation 54 and inhibits keratinocyte growth 55 . The level of prostanoids in the human skin epidermis is higher than that in the dermis 56 . Cytosolic phospholipase A 2 is activated by ceramide-1-phosphate, a lipid mediator that regulates the cleavage of arachidonic acid AA from glycerophospholipids 57, 58 . AA is converted to prostanoids by cyclooxygenase, producing 15-deoxy prostaglandin J 2 , a potent endogenous ligand of PPARs 59, 60 .
Sphingosine-1-phosphate and ceramides also induce keratinocyte differentiation 4, 6 . Thus, treatment with sphingoid bases may alter the levels of AA metabolites, ceramide-1-phosphate and sphingosine-1-phosphate, and these lipid mediators may affect keratinocyte differentiation. Sphingoid bases show impressive structural diversity 7, 8, 23 25 , but apart from their origins in mammals, little is known about the metabolism of individual sphingoid bases. In rat lymph cannulation experiments, orally administrated plant GlcCers containing 2-hydroxyl fatty acid were digested in the small intestine, and the resulting sphingoid bases were absorbed into small intestinal epithelial cells 19 . In lymph fluid from rats administered with GlcCers, plant-derived sphingoid bases and non-hydroxy fatty acid-containing ceramides were detected 22, 61 . These results indicate that sphingoid bases are absorbed from the intestines, and a proportion of plant-derived sphingoid bases appear to be resynthesized to form ceramides in small intestinal epithelial cells. Additionally, exogenously added d18:1, d18:0, and t18:0 are reconstructed to form ceramides in keratinocytes 26 . Therefore, A. amurensis-derived d18:3, 9Me-d18:3, and d22:2s may also be converted to ceramides in keratinocytes. Asterias amurensis-derived sphingoid bases containing ceramides or their metabolites may exhibit different bioactivities and exert specific effects. To determine the mechanisms underlying d18:3-specific bioactivities, we will investigate the absorption and metabolism of these sphingoid bases in keratinocytes and compare the bioactivities of associated metabolites on the differentiation and sphingolipid production in keratinocytes in future studies. Furthermore, the relationships between sphingoid base species, particularly d18:3, and skin barrier improvements will be studied in vivo. Such studies will provide important information regarding the development of more effective functional foods for promoting healthy skin conditions.
Conclusion
In this study, we isolated four sphingoid base species d18:3, 9Me-d18:3, and two d22:2 isomers from A. amurensis-derived GlcCers at high purity. Treatment of keratinocytes with d18:3 increased the saturated ULCFA-bound ceramide content and exposure to pure sphingoid bases induced the accumulation of ceramides and altered the amount of several sphingolipids. Structural differences between sphingoid bases clearly influences their ability to stimulate sphingolipid production in keratinocytes, particularly ULCFA-bound ceramides.
